MAIA Biotechnology Inc (MAIA)
3.28
+0.16
(+5.13%)
USD |
NYAM |
May 17, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Free Cash Flow (Quarterly): -3.587M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -3.587M |
December 31, 2023 | -3.992M |
September 30, 2023 | -3.157M |
June 30, 2023 | -2.561M |
March 31, 2023 | -3.361M |
December 31, 2022 | -2.950M |
September 30, 2022 | -4.319M |
Date | Value |
---|---|
June 30, 2022 | -2.019M |
March 31, 2022 | -2.808M |
December 31, 2021 | -1.607M |
September 30, 2021 | -1.311M |
June 30, 2021 | -0.951M |
March 31, 2021 | -0.2533M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.319M
Minimum
Sep 2022
-0.2533M
Maximum
Mar 2021
-2.529M
Average
-2.808M
Median
Mar 2022
Free Cash Flow (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | -3.91M |
Avid Bioservices Inc | -0.801M |
Oragenics Inc | -1.102M |
NeuBase Therapeutics Inc | -2.003M |
Viking Therapeutics Inc | -6.134M |